Medically Associated Science and Technology (MAST) Program

The Medically Associated Science and Technology (MAST) program at Cedars-Sinai is dedicated to the development of novel drugs and devices to diagnose and treat patients. MAST represents the main sail of a vessel taking us on a voyage of discovery in medicine and science. This innovative program is working to develop new diagnostics and therapeutics to treat patients with illnesses related to imbalances or alterations in the microbiome.

Deepening Comprehension of Digestive Diseases

Research breakthroughs in gut microbiome and other digestive diseases help experts improve diagnostic tools and protocols.

Patient Feature: Dreaming of Wellness

After years of misdiagnosis for her pain, Pam Emmer traveled from her home in the Midwest to Cedars-Sinai with the hope of finding a cure.

New Breath Test Diagnostics

Irritable bowel syndrome and small intestinal bacterial overgrowth have similar symptoms yet require different treatments—a new test can provide more accurate diagnosis.

Making Diabetes Easier to Treat

New insights into bariatric surgery, insulin pump technology, microbiome connection and insulin clearance present opportunities for diabetes research and treatments.

Featured Researcher

Discovery best happens at the bedside of patients by doctors and not just in a pharmaceutical lab."

Mark Pimentel, MD

Contact the Medically Associated Science and Technology (MAST) Program

8700 Beverly Blvd.
Los Angeles, CA 90048


Twitter: @mastprogram